From the Editor-in-Chief

The U.S. health care system must adapt to the needs of cancer survivors.

by William G. Nelson, MD, PhD

Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.

by Kate Yandell

Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.

by Kate Yandell

Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

by Anna Azvolinsky

Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.

by Marci A. Landsmann

Medical oncologist Gabrielle Rocque explains the role of clinical practice guidelines in breast cancer care.

by Anna Azvolinsky

Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.

by Marci A. Landsmann

National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.

by Marci A. Landsmann

Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

by Ashley P. Taylor

The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?

by Brad Jones